The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.
What does DTI stand for?
DTI stands for Direct Thrombin Inhibitor
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of DTI
We have 193 other meanings of DTI in our Acronym Attic
- Dial Test Indicator (mechanical measuring device used in machining)
- Diesel Turbo Intercooler (automobile)
- Diffusion Tensor Imaging
- Digital Technologies, Inc.
- Digital Technology International (news publishing; various locations)
- Digital Test Interface (Tollgrade)
- Digital Trunk Interface
- Digital Trunk Interface Frame (Sprint)
- Direcção de Tecnologias de Informação (Portuguese: Directorate of Information Technologies)
- Direct Tension Indicator (Applied Bolting Technology Products, Inc.)
- Direct Trader Input
- Directed Technologies, Inc.
- Direction de la Technique et de l'Innovation (French: Directorate of Technical and Innovation)
- Direction des Transmissions et de l'Informatique (French: Directorate of Communications and Information)
- Directive Technology Integrators (Oneonta, New York)
- Discrete Trial Instruction
- Distance through Insulation
- Distance to Intercept (US Air Force)
- Diversified Technology, Inc.
- Document Text Informationmanagement (various locations)
Samples in periodicals archive:
The oral direct thrombin inhibitor ximelagatran (pINN, formerly H 376/95) and its subcutaneous form melagatran compared with enoxaparin as thromboprophylaxis after total hip or total knee replacement [Abstract OC 1638].
The first direct thrombin inhibitor approved for HIT patients who are undergoing angioplasty.
About ANGIOMAX ANGIOMAX is a small-molecule, reversible, direct thrombin inhibitor that has been shown to reduce the incidence of death, myocardial infarction, and the need for revascularization in patients undergoing balloon angioplasty.
Demand for biotechnology cardiovascular and related agents will increase rapidly, led by new therapies for congestive heart failure, heparin-induced thrombocytopenia and thrombolytic surgical complications Direct thrombin inhibitors will exhibit the fastest growth based on expanding indications in surgery and emergency care.